Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/SMMT
icon
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Summit Therapeutics Inc (SMMT) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Summit Therapeutics trades at $15.37, showing modest daily gains of 1.59% amid significant volatility following recent positive clinical trial news. The stock faces bearish technical signals with negative profitability metrics including a -192.5% ROE and -$1.08B net loss for 2025. Recent catalysts include a $2 billion strategic investment from AstraZeneca and promising clinical trial results for cancer drug ivonescimab that have driven substantial price movements.
While analyst consensus remains strongly bullish with a $29.33 price target, the company faces execution risks in drug development and substantial cash burn. The AstraZeneca partnership provides validation but successful clinical outcomes remain critical for long-term value creation. Current valuation appears stretched given negative earnings and high P/B ratio of 18.53.
Read full analysis

Key Stats

  • Market Cap
    $11.67B
  • Volume
    4,313,704
  • Sector
    Health
  • 52W High
    $26.38
  • 52W Low
    $12.43
  • Typical Hold Time
    17 Days
  • Enterprise Value
    $11.00B
  • Div Yield
    -
  • Trading Activity
    -
$14.63
52W Low: $12.43
20 Aug 2026
52W High: $26.38
21 Apr 2026

Track Summit Therapeutics Inc (SMMT) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Summit Therapeutics Inc has traded between a low of $12.43 and a high of $26.38, highlighting its annual price range. Buy and sell Summit Therapeutics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Summit Therapeutics Inc

Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.

Most Recent News

Content is generated by Aura AI

Congress votes to release sexual misconduct settlement records amid major Trump admin updates on fraud, energy, and jobs.

In the 91st week of President Trump's second term, Congress voted unanimously (420-0) to publicly release taxpayer-funded sexual misconduct settlement records. The Trump administration also reported significant actions including dismantling millions ...

Market News
1 hour ago
Thinkcarebelieve
Bearish
news icon
Congress votes to release sexual misconduct settlement records amid major Trump admin updates on fraud, energy, and jobs.

Fidelity's Crypto Industry ETF rated Hold due to high volatility and funding challenges for miners.

The Fidelity Crypto Industry and Digital Payments ETF (FDIG) is rated a Hold as of October 14, 2026, trading around $39.4 with $235 million in assets and a 0.39% expense ratio. The fund is composed of roughly 66% crypto miners, mainly bitcoin miners,...

Market News
4 hours ago
Seeking Alpha
Neutral
Fidelity's Crypto Industry ETF rated Hold due to high volatility and funding challenges for miners.

Meta removes controversial AI training content scraping clause from its terms

Meta recently updated its commercial terms to allow use of content from business accounts for AI training, raising concerns about web scraping. After backlash and legal scrutiny, Meta clarified the terms only apply to ads and business products and do...

Market News
8 hours ago
TechCrunch
Neutral
Meta removes controversial AI training content scraping clause from its terms
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $11.67B
  • Volume
    4,313,704
  • Sector
    Health
  • 52W High
    $26.38
  • 52W Low
    $12.43
  • Typical Hold Time
    17 Days
  • Enterprise Value
    $11.00B
  • Div Yield
    -
  • Trading Activity
    -
$14.63
52W Low: $12.43
20 Aug 2026
52W High: $26.38
21 Apr 2026

Track Summit Therapeutics Inc (SMMT) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Summit Therapeutics Inc has traded between a low of $12.43 and a high of $26.38, highlighting its annual price range. Buy and sell Summit Therapeutics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!